Nirsevimab Reduced Hospitalizations for Infants With RSV

(MedPage Today) -- The monoclonal antibody nirsevimab (Beyfortus) reduced hospitalizations among infants with respiratory syncytial virus (RSV)-associated lower respiratory tract infection, the randomized, pragmatic HARMONIE trial showed. In over...
Source: MedPage Today Infectious Disease - Category: Infectious Diseases Source Type: news